Renovo plc
From Wikipedia, the free encyclopedia
| Type | Public limited company (LSE: RNVO) |
|---|---|
| Headquarters | Manchester, United Kingdom |
| Key people | Mark Ferguson (CEO) |
| Products | 5 in clinical development |
| Website | www.renovo.com |
Renovo Group plc (LSE: RNVO) is a biopharmaceutical company headquartered in Manchester, United Kingdom. It is a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration[1], and it aims "to be first to market with a scar prevention pharmaceutical drug in the US and Europe"[2] in approximately 2014.
Renovo is listed on the London Stock Exchange and is a constituent of the FTSE Fledgling Index.
[edit] Products
Renovo does not currently have any marketed products. Its development pipeline currently includes one drug in phase III clinical development, two drugs in phase II clinical development, and numerous pre-clinical candidates.[3]
| Drug | Phase | Action |
|---|---|---|
| Juvista | Phase III Clinical trial | Injected to the wound margins around the time of surgery causes a prevention or reduction of scarring through introduction of recombinant TGFβ3. |
| Adaprev | Phase II Clinical trial | Injected at the time of surgery for the prevention and reduction of scarring and adhesions between the tendon and surrounding tissues following tendon repair.]. |
| Prevascar | Phase II Clinical trial | Injected to the wound margins around the time of surgery causes a reduction of scarring through suppression of TGFβ1 and TGFβ2. |
| Juvidex | Renovo plans to partner Juvidex as a cosmetic ingredient for the improvement of skin appearance and to promote the healing of damaged skin. | |
| RN1005 | Phase I Clinical trial | RN1005 is an advanced preclinical candidate pharmaceutical, discovered by Renovo, targeting the Wnt pathway to reduce scarring and enhance tissue regeneration. |
[edit] References
[edit] External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
